Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript

Jun 01, 2022 / 02:00PM GMT
Lee Michael Hambright - Sanford C. Bernstein & Co., LLC., Research Division - Analyst

All right. Excellent. Well, thanks, everyone, for coming. I'm Lee Hambright, our U.S. medical devices analyst at Bernstein. We are thrilled to have Joaquin Duato, CEO of Johnson & Johnson. We're scheduled for a 50-minute fireside chat. Just a reminder, you can submit questions via the Pigeonhole link.

So Joaquin, first of all, thanks so much for joining us.

Joaquin Duato - Johnson & Johnson - CEO & Director

You're welcome.

Lee Michael Hambright - Sanford C. Bernstein & Co., LLC., Research Division - Analyst

Thanks for being here. You stepped into the CEO role in January, so it's been about 5 months now. I know you've had the opportunity to travel around, spend time with the J&J team and customers around the world. Maybe you could just kick us off with some opening remarks about the state of the business at J&J.

Joaquin Duato - Johnson & Johnson - CEO &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot